Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial
Long-term treatment with X/T over 52 weeks was safe, generally well tolerated, and associated with durable symptom improvement in people with schizophrenia.
Authors
- Colin Sauder (ORCID: https://orcid.org/0000-0002-0151-5191)
- Inder Kaul
- Stephen K. Brannan (ORCID: https://orcid.org/0000-0003-0922-5970)
- Soumya A. Chaturvedi
- Amy Claxton
- Sharon Sawchak
- Tejendra Patel
- Ronald Marcus
- Haiyuan Zhu
- David Brown
Institutions
- Austin Community College (US)
- Bristol-Myers Squibb (United States) (US)
Publication Details
- Journal
- American Journal of Psychiatry
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1176/appi.ajp.20241186
- Citations
- 2
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 66.25